NCT00999908 - Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Indacaterol 150 μg

Indacaterol was supplied in powder filled capsules together with a single dose dry powder inhaler (SDDPI) device.

DRUG

Tiotropium 18 μg

Tiotropium was supplied in powder filled capsules together with a single dose dry powder inhaler (SDDPI) device.

DRUG

Placebo

Placebo (matching indacaterol) was supplied in powder filled capsules together with a single dose dry powder inhaler (SDDPI) device.

Trial Locations (11)

Novartis Investigative Site, Bergamo

Novartis Investigative Site, Brescia

Novartis Investigative Site, Cava de' Tirreni

Novartis Investigative Site, Genova

Novartis Investigative Site, Milan

Novartis Investigative Site, Orbassano

Novartis Investigative Site, Pavia

Novartis Investigative Site, Reggio Emilia

Novartis Investigative Site, Sesto San Giovanni

Novartis Investigative Site, Treviso

Novartis Investigative Site, Verona